Cecília Garlanda

38.7k citations
251 papers · 28.6k · 12 hit papers · h-index 84

Impact in

  • Immunology top 0.02%
    • Biomarkers in Disease Mechanisms
    • Immune cells in cancer
    • Immune Cell Function and Interaction
    • Immune Response and Inflammation
    • IL-33, ST2, and ILC Pathways
    • Immunotherapy and Immune Responses
  • Oncology top 0.2%
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Biomarkers in Disease Mechanisms 121
    • Immune Response and Inflammation 42
    • Immune Cell Function and Interaction 36
    • IL-33, ST2, and ILC Pathways 25
    • Immune cells in cancer 22
    • Immunotherapy and Immune Responses 17
    • Inflammasome and immune disorders 27
    • Circular RNAs in diseases 15

Cecília Garlanda

245 papers receiving 28.1k citations

Cecília Garlanda's Hit Papers

Humoral Innate Immunity and Acute-Phase Proteins 2023 · 155 citations
1550+8+17Years since publication50010001.5k2.0k

Peers

Cecília Garlanda
Comparison fields: 5 of 166
  • Immunology 16.3k
  • Oncology 4.4k
  • Immunology and Allergy 859
  • Cancer Research 2.0k
  • Molecular Biology 7.7k
Replace Laurie H. Glimcher with:
Laurie H. Glimcher United States
Terje Espevik Norway
Massimo Locati Italy
Chen Dong United States
Gwendalyn J. Randolph United States
Jay K. Kolls United States
Mohamed Oukka United States
Hans‐Dieter Volk Germany
Bernhard Ryffel France
Klaus Pfeffer Germany
Cecília Garlanda relative to Laurie H. Glimcher United States Laurie H. Glimcher's profile →
Citations per field
00.5×1.6×
Laurie H. Glimcher · 1×
Citations per year

Countries citing papers authored by Cecília Garlanda

Since Specialization
Citations

This map shows the geographic impact of Cecília Garlanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecília Garlanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecília Garlanda more than expected).

Fields of papers citing papers by Cecília Garlanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecília Garlanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecília Garlanda. The network helps show where Cecília Garlanda may publish in the future.

Co-authors

The 25 scholars most cited alongside Cecília Garlanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cecília Garlanda Line = papers co-authored together Cecília Garlanda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 251 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Hit paper breakdown →
20092327
2
The Interleukin-1 Family: Back to the Future
Hit paper breakdown →
20131548
3
Macrophages as tools and targets in cancer therapy
Hit paper breakdown →
20221214
4
Central Role for G Protein-Coupled Phosphoinositide 3-Kinase γ in Inflammation
Hit paper breakdown →
20001057
5
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Hit paper breakdown →
2019779
6
PENTRAXINS AT THE CROSSROADS BETWEEN INNATE IMMUNITY, INFLAMMATION, MATRIX DEPOSITION, AND FEMALE FERTILITY
Hit paper breakdown →
2004714
7
AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch
Hit paper breakdown →
2011660
8
Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response
Hit paper breakdown →
2002566
9
The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Hit paper breakdown →
2008543
10
Tumor associated macrophages and neutrophils in cancer
Hit paper breakdown →
2013482
11
Involvement of endothelial PECAM-1/CD31 in angiogenesis.
1997477
12 2009467
13
Sexual Dimorphism in Innate Immunity
Hit paper breakdown →
2017450
14 2007442
15 1997421
16 2004394
17 2007372
18 2020366
19 2009354
20 2012346

About Cecília Garlanda

Cecília Garlanda is a scholar working on Immunology, Molecular Biology, Oncology, Parasitology and Infectious Diseases, having authored 251 papers that have together received 28.6k indexed citations. Recurring topics across this work include Biomarkers in Disease Mechanisms (121 papers), Immune Response and Inflammation (42 papers), Immune Cell Function and Interaction (36 papers), Inflammasome and immune disorders (27 papers), IL-33, ST2, and ILC Pathways (25 papers), Immune cells in cancer (22 papers), Immunotherapy and Immune Responses (17 papers) and Circular RNAs in diseases (15 papers). The work is most often cited by research in Immunology (16.3k citations), Oncology (4.4k citations), Immunology and Allergy (859 citations), Cancer Research (2.0k citations) and Molecular Biology (7.7k citations). Cecília Garlanda has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Alberto Mantovani, Paola Allavena, Barbara Bottazzi, Charles A. Dinarello, Antonio Sica, Sébastien Jaillon, Andrea Doni, Francesco Colotta, Federica Marchesi and Martina Molgora. Their work appears in journals such as The Journal of Immunology, Frontiers in Immunology, Blood, Seminars in Immunology and Immunological Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact